DexCom, Inc. (NASDAQ:DXCM) Files An 8-K Other Events

0

DexCom, Inc. (NASDAQ:DXCM) Files An 8-K Other Events

Item8.01

Other Events.

On May8, 2017, DexCom, Inc. (DexCom)
issued a press release announcing that it proposes to offer,
subject to market conditions and other factors, $300 million
aggregate principal amount of Convertible Senior Notes due 2022
(the Notes) in a private placement to
qualified institutional buyers to Rule 144A under the Securities
Act of 1933, as amended. DexCom also intends to grant the initial
purchasers of the Notes an option to purchase up to an additional
$45 million aggregate principal amount of Notes solely to cover
over-allotments, if any. Acopy of the press release announcing
the proposed offering of the Notes is attached hereto as Exhibit
99.1 and is incorporated herein by reference.

Item9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Number

Description

99.1 Press release dated May 8, 2017 announcing the proposed
offering of the Notes.


About DexCom, Inc. (NASDAQ:DXCM)

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products include SEVEN PLUS, DexCom G4, DexCom G4 PLATINUM, DexCom Share System and DexCom G5 Mobile. It had received Conformite Europeene Marking (CE Mark) approval for its fourth generation continuous glucose monitoring system, the DexCom G4 system, enabling commercialization of the DexCom G4 system. DexCom SHARE enables users of its G4 PLATINUM System to have their sensor glucose information remotely monitored by their family or friends. The G4 PLATINUM Receiver with Share uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient’s receiver and a mobile application on the patient’s iPhone to transmit glucose information.

DexCom, Inc. (NASDAQ:DXCM) Recent Trading Information

DexCom, Inc. (NASDAQ:DXCM) closed its last trading session up +0.83 at 76.21 with 2,159,607 shares trading hands.